Health economic analyses of current management of patients hospitalized with community-acquired pneumonia In Europe (2010-2011) : (Retrospective study to asess the clinical management of patients with moderate-to-Severe CSSTI Or CAP infections In the hospital setting [REACH]) : use of resources and consequences of treatment failure Read More: http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A2579
Altro
Data di Pubblicazione:
2012
Citazione:
Health economic analyses of current management of patients hospitalized with community-acquired pneumonia In Europe (2010-2011) : (Retrospective study to asess the clinical management of patients with moderate-to-Severe CSSTI Or CAP infections In the hospital setting [REACH]) : use of resources and consequences of treatment failure
Read More: http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A2579 / H. Ostermann, J. Garau, J. Medina, E. Pascual, K. Mcbride, F. Blasi. ((Intervento presentato al convegno ATS Conference tenutosi a San Francisco nel 2012.
Abstract:
Introduction: Community-acquired pneumonia (CAP) is associated with substantial economic burden to health care systems, especially
when hospitalization is required. The REACH study (NCT01293435) aimed to provide reliable data on current burden and clinical
management of CAP in hospitals across Europe, thus gaining an insight into how clinical outcomes affect economic burden. Presented
here are the health economic analyses of the study data.
Methods: REACH was a multinational, multicentre, observational, retrospective study of patients ≥18 years old hospitalized with CAP
requiring treatment with intravenous antibiotics. Variables collected via electronic Case Report Forms included patient demographics,
medical history, disease characteristics and severity (PORT/PSI, CURB-65), microbiological diagnosis, treatments before and during
hospitalization and health resource consumption.
Results: Mean duration of hospital stay for the population (N=2039) was 12.6 days (median: 10.0). Mean duration of stay in patients
admitted to ICU was 9.5 days (median: 5.0) (n=278). Hospital stay and resource use for patients with a recurrent infection or septic shock
versus those without either are shown in Table 1. Patients with treatment failure (n=757), defined as a need for antibiotic change, had
longer mean duration of hospital stay including more frequent, longer mean admissions to ICU than patients without failure. Patients with
treatment failure were also more likely to develop septic shock and had higher requirements for additional hospital resources such as
mechanical ventilation, parenteral nutrition, blood pressure support and renal replacement. Patients re-hospitalized after initial discharge
(recurrence) had an increased risk of treatment failure compared with patients presenting with their first infection (42.6%; n=40 vs 31.8%;
n=492), longer time to clinical stability (6.8 vs 5.4 days) and longer hospital stay (13.7 vs 11.5 days). Patients developing septic shock
(n=84) experienced longer hospital stays and required more hospital resources. No meaningful differences in duration of stay were
observed between patients with healthcare-associated pneumonia (HCAP; n=235) and those with CAP only (n=1558) (12.6 vs 11.8 days).
However, ICU admissions were shorter in HCAP patients than in CAP patients (5.2 vs 9.9 days). Immunosuppression, though rare, placed a
substantial burden on hospital resources. Overall mortality rate was 7.2% (n=147).
Conclusions: The REACH study demonstrated that treatment failure is common in CAP and HCAP patients in hospitals in Europe, and
results in a considerable burden of increased length of stay and increased need for additional support. Identifying susceptible patients and
improving initial antibiotic therapy is likely to improve outcomes and reduce hospital resource use.
Tipologia IRIS:
14 - Intervento a convegno non pubblicato
Elenco autori:
H. Ostermann, J. Garau, J. Medina, E. Pascual, K. Mcbride, F. Blasi
Link alla scheda completa: